128 related articles for article (PubMed ID: 7485348)
21. The effect of human immunodeficiency virus infection on birthweight, and infant and child mortality in urban Malawi.
Taha TE; Dallabetta GA; Canner JK; Chiphangwi JD; Liomba G; Hoover DR; Miotti PG
Int J Epidemiol; 1995 Oct; 24(5):1022-9. PubMed ID: 8557435
[TBL] [Abstract][Full Text] [Related]
22. Reduction in perinatal transmission and mortality from human immunodeficiency virus after intervention with zidovudine in Barbados.
St John AM; Kumar A; Cave C
Pediatr Infect Dis J; 2003 May; 22(5):422-6. PubMed ID: 12792382
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology and detection of human immunodeficiency virus among pregnant women in Hong Kong.
Ho KM; Ho KK; Lim WL; Li P; Wong KH
Hong Kong Med J; 2001 Dec; 7(4):335-42. PubMed ID: 11773666
[TBL] [Abstract][Full Text] [Related]
24. Pregnancy outcome among HIV-infected women in the Helsinki metropolitan area.
Lehtovirta P; Skogberg K; Salo E; Ammälä P; Ristola M; Suni J; Paavonen J; Heikinheimo O
Acta Obstet Gynecol Scand; 2005 Oct; 84(10):945-50. PubMed ID: 16167909
[TBL] [Abstract][Full Text] [Related]
25. Perinatal HIV transmission and the cost-effectiveness of screening at 14 weeks gestation, at the onset of labour and the rapid testing of infants.
Udeh B; Udeh C; Graves N
BMC Infect Dis; 2008 Dec; 8():174. PubMed ID: 19117527
[TBL] [Abstract][Full Text] [Related]
26. Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India.
Kumar M; Birch S; Maturana A; Gafni A
Health Policy; 2006 Jul; 77(2):233-43. PubMed ID: 16126300
[TBL] [Abstract][Full Text] [Related]
27. Serosurvey of human immunodeficiency virus infection in parturients. Implications for human immunodeficiency virus testing programs of pregnant women.
Landesman S; Minkoff H; Holman S; McCalla S; Sijin O
JAMA; 1987 Nov; 258(19):2701-3. PubMed ID: 3312662
[TBL] [Abstract][Full Text] [Related]
28. Update: perinatally acquired HIV/AIDS--United States, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Nov; 46(46):1086-92. PubMed ID: 9385878
[TBL] [Abstract][Full Text] [Related]
29. Human immunodeficiency virus infection among inner-city adolescent parturients undergoing routine voluntary screening, July 1987 to March 1991.
Lindsay MK; Johnson N; Peterson HB; Willis S; Williams H; Klein L
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 1):1096-9. PubMed ID: 1415397
[TBL] [Abstract][Full Text] [Related]
30. Rapid HIV versus enzyme-linked immunosorbent assay screening in a low-risk Mexican American population presenting in labor: a cost-effectiveness analysis.
Doyle NM; Levison JE; Gardner MO
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1280-5. PubMed ID: 16157152
[TBL] [Abstract][Full Text] [Related]
31. Prenatal HIV testing and antiretroviral prophylaxis at an urban hospital--Atlanta, Georgia, 1997-2000.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Jan; 52(51-52):1245-8. PubMed ID: 14704648
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B virus, human immunodeficiency virus type-1, and syphilis among women attending prenatal clinics in Belize, Central America.
Scott-Wright A; Hakre S; Bryan JP; Jaramillo R; Reyes LG; Cruess D; Macarthy PO; Gaydos JC
Am J Trop Med Hyg; 1997 Mar; 56(3):285-90. PubMed ID: 9129530
[TBL] [Abstract][Full Text] [Related]
33. Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis.
Plunkett BA; Grobman WA
Am J Obstet Gynecol; 2005 Apr; 192(4):1153-61. PubMed ID: 15846195
[TBL] [Abstract][Full Text] [Related]
34. Survey of the prevalence of HIV infection in an antenatal population in South Dakota.
Dimitrievich E; Watson WJ
S D J Med; 1998 Jul; 51(7):229-32. PubMed ID: 9676156
[TBL] [Abstract][Full Text] [Related]
35. A protocol for routine voluntary antepartum human immunodeficiency virus antibody screening.
Lindsay MK
Am J Obstet Gynecol; 1993 Feb; 168(2):476-9. PubMed ID: 8438912
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in pediatric HIV.
Menard J; Tucker NC; Darville T
J Ark Med Soc; 1995 Sep; 92(4):165-8. PubMed ID: 7592235
[TBL] [Abstract][Full Text] [Related]
37. Would universal antenatal screening for HIV infection be cost-effective in a setting of very low prevalence? Modelling the data for Australia.
Graves N; Walker DG; McDonald AM; Kaldor JM; Ziegler JB
J Infect Dis; 2004 Jul; 190(1):166-74. PubMed ID: 15195257
[TBL] [Abstract][Full Text] [Related]
38. A study to determine the incidence and prevalence of newly discovered human immunodeficiency virus infection during the prenatal care period.
Grimes RM; Srivastava G; Helfgott AW; Eriksen NL
Infect Dis Obstet Gynecol; 2000; 8(3-4):172-5. PubMed ID: 10968601
[TBL] [Abstract][Full Text] [Related]
39. Incidence and prevalence of human immunodeficiency virus infection in a prenatal population undergoing routine voluntary human immunodeficiency virus screening, July 1987 to June 1990.
Lindsay MK; Peterson HB; Willis S; Slade BA; Gramling J; Williams H; Klein L
Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 1):961-4. PubMed ID: 1951563
[TBL] [Abstract][Full Text] [Related]
40. Use of anonymous newborn serosurveys to evaluate antenatal HIV screening programmes.
Holland FJ; Ades AE; Davison CF; Parker S; Berry T; Hjelm M; Wilcox AH; Cubitt D; Hudson CN; Peckham CS
J Med Screen; 1994 Jul; 1(3):176-9. PubMed ID: 8790512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
